Food and Cosmetics
Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.
Our Life Sciences team has experience of advising many cosmetic and food companies, including Cargill, LVMH Perfumes and Cosmetics, Primark, United Biscuits, McDonalds, Heineken, Kraft Foods Inc, Nestlé, British Sugar and Heinz, among others. We have advised on issues including health claims, composition and labelling requirements, and various marketing issues. Our lawyers know the issues the industry faces and understand how to deal with them. The team has the added benefit of being fully integrated into Allen & Overy’s broader Life Sciences team and benefits from insights and expertise from our dedicated Life Sciences regulatory group.
Explore our sectors
Meet our lawyers
News & insights
Publications: 19 FEBRUARY 2020
Phase One Sino–U.S. trade agreement and the pharmaceutical industry
On 16 January 2020, China and the United States signed the Economic and Trade Agreement between the Government of the People’s Republic of China and the Government of the United States of America (the Phase One Trade Agreement).
Read more
Publications: 29 NOVEMBER 2019
As more countries liberalise their cannabis policies, there has been a rapid increase in the number of registered IP rights as competitors seek to establish their places in the market.
Read more
Publications: 04 OCTOBER 2019
Outstanding performance by A&O in global M&A league tables
A&O has marked the end of Q3 2019 with an outstanding performance in the M&A league tables; the result of advising on a number of complex, high-value transactions in a wide range of sectors and markets, around our global network in 2019.
Read more
Publications: 28 AUGUST 2019
NICE consults on Draft Guideline on prescribing medicinal cannabis
On 8 August 2019, the National Institute for Health and Care Excellence (NICE)1 published a draft guideline on prescribing cannabis-based medicinal products (the Draft Guideline) for consultation.2
Read moreDownload our sector brochure
